| Literature DB >> 32199616 |
Masayuki Nagasawa1, Kosuke Tomimatsu2, Koji Terada2, Kenta Kondo2, Kazuko Miyazaki3, Masaki Miyazaki3, Daisuke Motooka4, Daisuke Okuzaki4, Tetsuya Yoshida5, Susumu Kageyama5, Hiroshi Kawamoto3, Akihiro Kawauchi5, Yasutoshi Agata6.
Abstract
Androgen receptor (AR)-negative castration-resistant prostate cancer (CRPC) is highly aggressive and is resistant to most of the current therapies. Bromodomain and extra terminal domain (BET) protein BRD4 binds to super-enhancers (SEs) that drive high expression of oncogenes in many cancers. A BET inhibitor, JQ1, has been found to suppress the malignant phenotypes of prostate cancer cells, however, the target genes of JQ1 remain largely unknown. Here we show that SE-associated genes specific for AR-negative CRPC PC3 cells include genes involved in migration and invasion, and that JQ1 impairs migration and invasion of PC3 cells. We identified a long non-coding RNA, MANCR, which was markedly down-regulated by JQ1, and found that BRD4 binds to the MANCR locus. MANCR knockdown led to a significant decrease in migration and invasion of PC3 cells. Furthermore, RNA sequencing analysis revealed that expression of the genes involved in migration and invasion was altered by MANCR knockdown. In summary, our data demonstrate that MANCR plays a critical role in migration and invasion of PC3 cells.Entities:
Keywords: BET protein inhibitor; Epithelial-mesenchymal transition; MANCR; Prostate cancer; Super-enhancer; lncRNA
Year: 2020 PMID: 32199616 DOI: 10.1016/j.bbrc.2020.03.043
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575